Department of Anesthesiology and Pain Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Blood Purif. 2022;51(1):62-69. doi: 10.1159/000515685. Epub 2021 Apr 28.
Polymyxin B-immobilized fiber column direct hemoperfusion (PMX-DHP) is used for patients with septic shock, and the recommended hemoperfusion period is 2 h. However, it remains unclear whether the optimal duration is 2 h or longer. The purpose of this study was to compare the effects of PMX-DHP between conventional and longer duration of PMX-DHP.
We retrospectively investigated 103 patients with sepsis who underwent PMX-DHP. The demographic data, routine biochemistry, microbiological data, and primary infection site were reviewed in the medical chart. The acute physiology and chronic health evaluation (APACHE) II score, sequential organ failure assessment (SOFA) score, heart rate, mean arterial pressure (MAP), vasoactive-inotropic score (VIS), and PaO2/FiO2, at baseline and day 3, were compared between the standard group (2 h of PMX-DHP) and the extended group (>2 h of PMX-DHP).
Median MAP was significantly lower and median VIS was significantly higher in the extended group at baseline (p < 0.05, 0.01, respectively) There were no significant differences in APACHE II score, SOFA score, and PaO2/FiO2 at baseline between the 2 groups. The increase of MAP and the decrease in VIS from baseline to day 3 were significantly greater in the extended group (p < 0.01, respectively). In the extended group, increase in PaO2/FiO2 was significantly larger in the patients who underwent ≥8 h duration than that in patients who underwent <8 h duration (p < 0.01). The ventilator-free days, the incidence of continuous renal replacement therapy, and the 28-day mortality were not different between the groups.
DISCUSSION/CONCLUSIONS: Longer duration of PMX-DHP was associated with the improved MAP and decreased volume of vasoactive-inotropic agents compared with the conventional duration. Eight and longer hours duration of PMX-DHP was associated with the improvement in the pulmonary oxygenation. Further studies are needed to confirm the efficacy of longer duration of PMX-DHP in patients with septic shock.
多粘菌素 B 固定纤维柱直接血液灌流(PMX-DHP)用于治疗感染性休克患者,建议的血液灌流时间为 2 小时。然而,目前尚不清楚最佳时间是 2 小时还是更长时间。本研究旨在比较 PMX-DHP 的常规和延长时间的效果。
我们回顾性调查了 103 例接受 PMX-DHP 的败血症患者。从病历中查阅了人口统计学数据、常规生化、微生物学数据和主要感染部位。比较了标准组(PMX-DHP 2 小时)和延长组(PMX-DHP>2 小时)的急性生理学和慢性健康评估(APACHE)II 评分、序贯器官衰竭评估(SOFA)评分、心率、平均动脉压(MAP)、血管活性-正性肌力评分(VIS)和 PaO2/FiO2 在基线和第 3 天的差异。
延长组的 MAP 中位数明显较低,VIS 中位数明显较高,差异有统计学意义(p<0.05,0.01)。两组的 APACHE II 评分、SOFA 评分和 PaO2/FiO2 在基线时差异无统计学意义。与基线相比,延长组的 MAP 增加和 VIS 降低在第 3 天更为显著(p<0.01)。在延长组中,持续时间≥8 小时的患者的 PaO2/FiO2 增加量明显大于持续时间<8 小时的患者(p<0.01)。两组的无呼吸机天数、持续肾脏替代治疗的发生率和 28 天死亡率无差异。
讨论/结论:与常规时间相比,PMX-DHP 的延长时间与 MAP 的升高和血管活性-正性肌力药物的减少有关。PMX-DHP 持续时间为 8 小时或更长时间与肺氧合的改善有关。需要进一步的研究来证实 PMX-DHP 的延长时间在感染性休克患者中的疗效。